These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21740030)

  • 1. Identifying new persistent and bioaccumulative organics among chemicals in commerce II: pharmaceuticals.
    Howard PH; Muir DC
    Environ Sci Technol; 2011 Aug; 45(16):6938-46. PubMed ID: 21740030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying new persistent and bioaccumulative organics among chemicals in commerce.
    Howard PH; Muir DC
    Environ Sci Technol; 2010 Apr; 44(7):2277-85. PubMed ID: 20163179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying new persistent and bioaccumulative organics among chemicals in commerce. III: byproducts, impurities, and transformation products.
    Howard PH; Muir DC
    Environ Sci Technol; 2013 May; 47(10):5259-66. PubMed ID: 23594256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures.
    Klecka G; Persoon C; Currie R
    Rev Environ Contam Toxicol; 2010; 207():1-93. PubMed ID: 20652664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of 'emerging' organic contaminants in biosolids and assessment of international research priorities for the agricultural use of biosolids.
    Clarke BO; Smith SR
    Environ Int; 2011 Jan; 37(1):226-47. PubMed ID: 20797791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are there other persistent organic pollutants? A challenge for environmental chemists.
    Muir DC; Howard PH
    Environ Sci Technol; 2006 Dec; 40(23):7157-66. PubMed ID: 17180962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of persistent organic pollutants by QSPR classification models: a comparative study.
    Papa E; Gramatica P
    J Mol Graph Model; 2008 Aug; 27(1):59-65. PubMed ID: 18387326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening organic chemicals in commerce for emissions in the context of environmental and human exposure.
    Breivik K; Arnot JA; Brown TN; McLachlan MS; Wania F
    J Environ Monit; 2012 Aug; 14(8):2028-37. PubMed ID: 22785348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment.
    Cooper ER; Siewicki TC; Phillips K
    Sci Total Environ; 2008 Jul; 398(1-3):26-33. PubMed ID: 18440598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States--II) untreated drinking water sources.
    Focazio MJ; Kolpin DW; Barnes KK; Furlong ET; Meyer MT; Zaugg SD; Barber LB; Thurman ME
    Sci Total Environ; 2008 Sep; 402(2-3):201-16. PubMed ID: 18433838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of polar organic integrative samplers for analysis of pharmaceuticals in aquatic systems.
    Togola A; Budzinski H
    Anal Chem; 2007 Sep; 79(17):6734-41. PubMed ID: 17683162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illicit drugs: contaminants in the environment and utility in forensic epidemiology.
    Daughton CG
    Rev Environ Contam Toxicol; 2011; 210():59-110. PubMed ID: 21170703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
    Kimura K; Iwase T; Kita S; Watanabe Y
    Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceuticals and other organic chemicals in selected north-central and northwestern Arkansas streams.
    Haggard BE; Galloway JM; Green WR; Meyer MT
    J Environ Qual; 2006; 35(4):1078-87. PubMed ID: 16738393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time.
    Gibs J; Stackelberg PE; Furlong ET; Meyer M; Zaugg SD; Lippincott RL
    Sci Total Environ; 2007 Feb; 373(1):240-9. PubMed ID: 17188338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant.
    Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
    Sci Total Environ; 2004 Aug; 329(1-3):99-113. PubMed ID: 15262161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meeting the challenge of identifying persistent pollutants at the state level.
    Hope BK; Stone D; Fuji T; Gensemer RW; Jenkins J
    Integr Environ Assess Manag; 2010 Oct; 6(4):735-48. PubMed ID: 20872652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of pharmaceutically active compounds in Doñana Park (Spain) main watersheds.
    Camacho-Muñoz MD; Santos JL; Aparicio I; Alonso E
    J Hazard Mater; 2010 May; 177(1-3):1159-62. PubMed ID: 20122798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput identification of microbial transformation products of organic micropollutants.
    Helbling DE; Hollender J; Kohler HP; Singer H; Fenner K
    Environ Sci Technol; 2010 Sep; 44(17):6621-7. PubMed ID: 20799730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction to special series: science-based guidance and framework for the evaluation and identification of PBTs and POPs.
    Klecka GM; Muir DC; Dohmen P; Eisenreich SJ; Gobas FA; Jones KC; Mackay D; Tarazona JV; van Wijk D
    Integr Environ Assess Manag; 2009 Oct; 5(4):535-8. PubMed ID: 19552505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.